This inventor holds 2 USPTO granted patents. Top assignee: K.v. Pharmaceutical Company. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2008
Title: The Innovations of Donald J Barbieri
Introduction
Donald J Barbieri is a notable inventor based in Fenton, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of rapidly disintegrating tablets. With a total of two patents to his name, Barbieri's work has the potential to enhance the efficiency of drug delivery systems.
Latest Patents
Barbieri's latest patents focus on the creation of rapidly disintegrating tablets. These inventions provide a formulation that includes an active ingredient, a water-soluble, directly compressible carbohydrate, and a water-soluble, directly compressible filler. The method of producing these tablets involves wet granulating a mixture that consists of a directly compressible, water-soluble carbohydrate, a directly compressible, water-insoluble filler, a beneficial ingredient, and a solvent. The granulate is then compressed to produce the final tablet.
Career Highlights
Throughout his career, Donald J Barbieri has been associated with K.V. Pharmaceutical Company, where he has applied his expertise in pharmaceutical innovations. His work has contributed to advancements in medication formulations that are more effective and user-friendly.
Collaborations
Barbieri has collaborated with notable colleagues, including Michael N Grimshaw and Louise M Vizzini. These partnerships have likely fostered a creative environment that encourages innovation and the development of new pharmaceutical solutions.
Conclusion
Donald J Barbieri's contributions to the field of pharmaceuticals, particularly through his patents for rapidly disintegrating tablets, showcase his commitment to improving drug delivery systems. His work continues to influence the industry and enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile